AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Precision Peptide Company Inc

$0.20 -$0.00 (-0.49%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$0.20
Day Range
$0.20$0.24
Year Range
$0.01$0.41
Market Cap
3.1M
AVG Volume
44.46K
Trailing/Forward PE
-1.81/-
PEG ratio
-0.02
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD) · A
0200K400K600K2022202320242025
PNGAF Revenue (CAD) by year
PeriodRevenue (CAD)
202549.71K
202412.2K
2023285.59K
2022447.12K
Net Income (CAD) · A
-6M-4M-2M02022202320242025
PNGAF Net Income (CAD) by year
PeriodNet Income (CAD)
2025-4.58M
2024-1.03M
2023-1.65M
2022-1.06M
Operating Income (CAD) · A
-3M-2M-1M02022202320242025
PNGAF Operating Income (CAD) by year
PeriodOperating Income (CAD)
2025-2.25M
2024-982.07K
2023-1.64M
2022-784.59K
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (CAD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: PNGAF

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

Precision Peptide Company Inc
PNGAF
Stockpicker

Video analysis: PNGAF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PNGAF

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.